FDA Brief

Warning letters Food

FDA warning letter to

EU Natural Inc.

High riskIssued May 20, 2021Posted May 26, 2021Center for Food Safety and Applied Nutrition

EU Natural's fertility supplements are unapproved new drugs because website claims treat infertility, PCOS, cancer and other diseases.

What happened

FDA reviewed www.store.eunatural.com in March 2021 and the company's Instagram account, which directs consumers to the store, and found the company takes orders there for CONCEPTION Female Fertility Prenatal and CONCEPTION MEN Male Fertility. FDA found website and social media claims that the products or their ingredients treat or prevent diseases including infertility, PCOS, endometriosis, depression, arthritis, diabetes, cancer, and insomnia. FTC also reviewed the websites in May 2021 and said some efficacy claims may lack competent and reliable scientific evidence.

What FDA found

  1. Website and Instagram claims show the fertility supplements are intended to cure, mitigate, treat, or prevent diseases, so they are drugs under the law.

    FD&C Act § 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]
  2. The products are unapproved new drugs because they are not generally recognized as safe and effective for the claimed disease uses and lack FDA approval.

    FD&C Act §§ 201(p), 505(a), 301(d) [21 U.S.C. §§ 321(p), 355(a), 331(d)]
  3. The products are misbranded because they do not bear adequate directions for use by a layperson for diseases that require a licensed practitioner.

    FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]
  4. FTC says the disease-related advertising claims may not be supported by competent and reliable scientific evidence.

    FTC Act § 5 [15 U.S.C. § 45]

What FDA wants

FDA asks the company to reply in writing within 15 working days describing the specific steps taken to correct the violations and prevent recurrence, including documentation, or to explain why it cannot complete them and when it will. FTC also asks for notice within 15 working days of actions taken to address its concerns.

Who should pay attention

  • supplement brands and marketers making fertility or disease-related claims
  • retailers and online marketplaces selling fertility supplements
  • advertising and social media teams for supplement companies

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk